Ocean Biomedical - OCEA Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $17.63
  • Forecasted Upside: 1,266.67%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$1.29
▼ -0.01 (-0.77%)
Get New Ocean Biomedical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for OCEA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for OCEA

Analyst Price Target is $17.63
▲ +1,266.67% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Ocean Biomedical in the last 3 months. The average price target is $17.63, with a high forecast of $17.63 and a low forecast of $17.63. The average price target represents a 1,266.67% upside from the last price of $1.29.

This chart shows the closing price for OCEA for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 1 contributing investment analysts is to buy stock in Ocean Biomedical. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/1/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/1/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/30/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/28/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/27/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/26/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/25/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/24/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/29/2023Fundamental ResearchSet TargetBuy$17.63N/A
4/13/2023EF Hutton Acquisition Co. IReiterated RatingBuy$10.00N/A
3/21/2023Fundamental ResearchSet TargetBuy$16.40N/A
3/13/2023EF Hutton Acquisition Co. IInitiated CoverageBuy$10.00N/A
(Data available from 6/24/2019 forward)

News Sentiment Rating

-0.15 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/27/2023
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 2 very negative mentions
12/27/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
1/26/2024
  • 0 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/25/2024
  • 3 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/26/2024
  • 0 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
4/25/2024
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/25/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
6/24/2024

Current Sentiment

  • 0 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Ocean Biomedical

Aesther Healthcare Acquisition Corp. entered into definitive merger agreement with Ocean Biomedical, Inc.
Read More

Today's Range

Now: $1.29
Low: $1.27
High: $1.34

50 Day Range

MA: N/A

52 Week Range

Now: $1.29

Volume

89,862 shs

Average Volume

158,782 shs

Market Capitalization

$44.70 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.62

Frequently Asked Questions

What sell-side analysts currently cover shares of Ocean Biomedical?

The following equities research analysts have issued stock ratings on Ocean Biomedical in the last twelve months: Fundamental Research.
View the latest analyst ratings for OCEA.

What is the current price target for Ocean Biomedical?

1 Wall Street analysts have set twelve-month price targets for Ocean Biomedical in the last year. Their average twelve-month price target is $17.63, suggesting a possible upside of 1,266.7%. Fundamental Research has the highest price target set, predicting OCEA will reach $17.63 in the next twelve months. Fundamental Research has the lowest price target set, forecasting a price of $17.63 for Ocean Biomedical in the next year.
View the latest price targets for OCEA.

What is the current consensus analyst rating for Ocean Biomedical?

Ocean Biomedical currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe OCEA will outperform the market and that investors should add to their positions of Ocean Biomedical.
View the latest ratings for OCEA.

What other companies compete with Ocean Biomedical?

How do I contact Ocean Biomedical's investor relations team?

Ocean Biomedical's physical mailing address is 515 Madison Avenue Suite 8078, New York NY, 10022. The company's listed phone number is 646-908-2658 and its investor relations email address is 0. The official website for Ocean Biomedical is 0. Learn More about contacing Ocean Biomedical investor relations.